17530-69-7

Basic information

• Product Name: 3-CHLORO-5,5-DIMETHYL-2-CYCLOHEXEN-1-ONE
• Synonyms: LABOTEST-BB LT01147600;3-CHLORO-5,5-DIMETHYL-2-CYCLOHEXEN-1-ONE;3-CHLORO-5,5-DIMETHYLCYCLOHEX-2-EN-1-ONE;3-Chloro-5,5-dimethyl-2-cyclohexenone;5,5-Dimethyl-3-chloro-2-cyclohexen-1-one;5,5-Dimethyl-3-chlorocyclohex-2-enone;NISTC17530697;3-Chloro-5,5-dimethy1-2-cyclohexen-1-one
• CAS NO: 17530-69-7
• Molecular Formula: C₈H₁₁ClO
• Molecular Weight: 158.63
• Mol File: 17530-69-7.mol

Chemical Properties

• Boiling Point: 44-46°C 0,1mm
• Flash Point: 44-46°C/0.1mm
• Appearance: /
• Density: 1,084 g/cm3
• Vapor Pressure: 0.131mmHg at 25°C
• Refractive Index: 1.488
• Storage Temp.: Sealed in dry,Room Temperature
• BRN: 1099253
• CAS DataBase Reference: 3-CHLORO-5,5-DIMETHYL-2-CYCLOHEXEN-1-ONE(CAS DataBase Reference)
• NIST Chemistry Reference: 3-CHLORO-5,5-DIMETHYL-2-CYCLOHEXEN-1-ONE(17530-69-7)
• EPA Substance Registry System: 3-CHLORO-5,5-DIMETHYL-2-CYCLOHEXEN-1-ONE(17530-69-7)

Safety Data

• Statements: 36/37/38
• Safety Statements: 26-37/39
• Hazardous Substances Data: 17530-69-7(Hazardous Substances Data)

Usage

Synthesis Reference(s)

Tetrahedron Letters, 30, p. 3753, 1989 DOI: 10.1016/S0040-4039(01)80646-8

InChI:InChI=1/C8H11ClO/c1-8(2)4-6(9)3-7(10)5-8/h3H,4-5H2,1-2H3

Upstream product

• 126-81-8 dimedone 
• 18922-00-4 5,5-dimethyl-3-oxocyclohex-1-en-1-yl methanesulfonate 
• 67-66-3 chloroform 
• 7719-12-2 phosphorus trichloride 
• 79-37-8 oxalyl dichloride 
• 10026-13-8 phosphorus pentachloride 
• 36646-78-3 3-(p-tolylamino)-5,5-dimethylcyclohex-2-enone 
• 120623-63-4 5,5-Dimethyl-2-(tributyl-λ⁵-phosphanylidene)-cyclohexane-1,3-dione 
• 3471-13-4 dimedone 

Downstream Products

• 65695-53-6 5,5-dimethyl-3-p-toluidino-cyclohex-2-en-one-p-tolylimine 
• 72035-58-6 3-(4-Fluoro-phenoxy)-5,5-dimethyl-cyclohex-2-enone 
• 151450-01-0 Acetic acid (E)-4-(5,5-dimethyl-3-oxo-cyclohex-1-enyl)-non-4-enyl ester 
• 76399-17-2 (E)-3-chloro-5,5-dimethyl-2-cyclohexenylidene acetonitrile 
• 76399-16-1 (Z)-3-chloro-5,5-dimethyl-2-cyclohexenylidene acetonitrile 
• 138421-75-7 methyl 1-(2-chloro-4,4-dimethyl-6-oxocyclohex-1-enyl)ethylcarbamate 
• 6502-98-3 5,5-dimethyl-3-[(E)-2-phenylvinyl]cyclohex-2-en-1-one 
• 110897-39-7 5,5-Dimethyl-3-((Z)-1-methyl-hex-1-enyl)-cyclohex-2-enone 
• 75539-86-5 5,5-dimethyl-3-methylsulphonylcyclohex-2-enone 
• 70606-96-1 5,5-Dimethyl-3-(p-tolyl)sulfonyl-2-cyclohexen-1-on 
• 4683-45-8 3-methoxy-5,5-dimethyl-cyclohex-2-enone 
• 52735-55-4 5,5-Dimethyl-3-phenylsulfonyl-2-cyclohexen-1-on 
• 63858-64-0 9,9-dimethyl-spiro[4.5]decan-7-one 
• 108377-94-2 3-((Z)-But-1-enyl)-5,5-dimethyl-cyclohex-2-enone 

Relevant articles and documents

NOVEL CYP17 INHIBITORS/ANTIANDROGENS

Compounds of formula (I), wherein R1 to R8 A, B, Z1 and Z2 are as defined in the claims and pharmaceutically acceptable salts and esters thereof are disclosed. The compounds of formula (I) possess utility as androgen receptor antagonists (inhibitors) and/or cytochrome P450 monooxygenase 17a-hydroxylase/17,20-lyase (CYP17) inhibitors. The compounds are useful as medicaments in the treatment of cancer, particularly prostate cancer, and other androgen dependent conditions and diseases where androgen antagonism is desired.

An approach toward the synthesis of PPAP natural product garsubellin A: Construction of the tricyclic core

In a study directed toward the bioactive natural product garsubellin A, an expedient route to the bicyclo[3.3.1]nonan-9-one bearing tricyclic core, with a bridgehead anchored tetrahydrofuran ring, is delineated. The approach emanating from commercially av

COMPOUNDS FOR THE TREATMENT AND PREVENTION OF INFLUENZA

A compound of formula (I) as well as pharmaceutically acceptable salt thereof, wherein R1 to R4 and Ar are as defined in description and in claims, can be used as a medicament.

COMPOUNDS FOR THE TREATMENT AND PREVENTION OF INFLUENZA

A compound of formula (I) as well as pharmaceutically acceptable salt thereof, wherein R1 to R4 and Ar are as defined in description and in claims, can be used as a medicament.

COMPOUNDS FOR THE TREATMENT AND PREVENTION OF INFLUENZA

A compound of formula (I) as well as pharmaceutically acceptable salt thereof, wherein R1 to R4 and Ar are as defined in description and in claims, can be used as a medicament.

NEW TETRAHYDROPYRAZOLO[3,4-C]ISOQUINOLIN-5-AMINE DERIVATIVES

New tetrahydropyrazolo[3,4-c]isoquinolin-5-amine derivatives having the chemical structure of formula (I) are disclosed; as well as process for their preparation, pharmaceutical compositions comprising them and their use in therapy as inhibitors of the phosphodiesterase IV (PDE4).

Studies in aza-Claisen rearrangement: Synthesis of dimedone-annelated unusual heterocycles

A number of 3-N-(4′-aryloxybut-2′-ynyl)N-methyl amino-5,5-dimethyl cyclohex-2-enones are synthesized in 62-65% yield by refluxing 3-chloro-5,5-dimethyl cyclohex-2-enone with a number of 4-aryloxy-4-chlorobut-2-ynes in ethanol for 4 h. The amines are then

Chlorine substitution reactions using trichloroisocyanuric acid with triphenylphosphine

Trichloroisocyanuric acid with triphenylphosphine in anhydrous acetonitrile will convert alcohols into alkyl halides, carboxylic acids into acid chlorides, 1,3-diketones into vinyl chlorides, and amides into nitriles.

2,3,6,7,8,9-hexahydro-8,8-dimethyl-5-phenyl-1H-1,4-benzodiazepin-6-one

Several approaches for the synthesis of the title compound 1 were investigated. Treatment of the ethane-1,2-diamine derivative 2 with phosphoryl chloride afforded 3-chloro-5,5-dimethylcyclohex-2-enone (3) and 1-(5,5-dimethyl-3-oxocyclohex-1-enyl)-4,5-dihydro-2-phenylimidazole (4). The reaction of 2-benzoyldimedone (5) with an equimolar amount of ethane-1,2-diamine led to the 2:1 adduct 6, whereas with an excess of ethane-1,2-diamine, 4,5-dihydro-2-phenylimidazole (7) and dimedone were obtained. The synthesis of the title compound 1 was achieved by reacting 2-benzoyl-3-chloro-5,5-dimethylcyclohex-2-enone (8) with ethane-1,2-diamine.